| Year |
Citation |
Score |
| 2016 |
Kraan TC, Ising HK, Fokkema M, Velthorst E, van den Berg DP, Kerkhoven M, Veling W, Smit F, Linszen DH, Nieman DH, Wunderink L, Boonstra N, Klaassen RM, Dragt S, Rietdijk J, et al. The effect of childhood adversity on 4-year outcome in individuals at ultra high risk for psychosis in the Dutch Early Detection Intervention Evaluation (EDIE-NL) Trial. Psychiatry Research. 247: 55-62. PMID 27863320 DOI: 10.1016/J.Psychres.2016.11.014 |
0.301 |
|
| 2016 |
van Bebber J, Wigman JT, Meijer RR, Ising HK, van den Berg D, Rietdijk J, Dragt S, Klaassen R, Nieman D, de Jonge P, Sytema S, Wichers M, Linszen D, van der Gaag M, Wunderink L. The Prodromal Questionnaire: a case for IRT-based adaptive testing of psychotic experiences? International Journal of Methods in Psychiatric Research. PMID 27468957 DOI: 10.1002/Mpr.1518 |
0.349 |
|
| 2016 |
Ising HK, Ruhrmann S, Burger NAFM, Rietdijk J, Dragt S, Klaassen RMC, van den Berg DPG, Nieman DH, Boonstra N, Linszen DH, Wunderink L, Smit F, Veling W, van der Gaag M. Development of a stage-dependent prognostic model to predict psychosis in ultra-high-risk patients seeking treatment for co-morbid psychiatric disorders Psychological Medicine. 1-13. DOI: 10.1017/S0033291716000325 |
0.357 |
|
| 2016 |
Salokangas RKR, Schultze-Lutter F, Hietala J, Heinimaa M, From T, Ilonen T, Löyttyniemi E, von Reventlow HG, Juckel G, Linszen D, Dingemans P, Birchwood M, Patterson P, Klosterkötter J, Ruhrmann S. Depression predicts persistence of paranoia in clinical high-risk patients to psychosis: results of the EPOS project Social Psychiatry and Psychiatric Epidemiology. 51: 247-257. DOI: 10.1007/S00127-015-1160-9 |
0.337 |
|
| 2015 |
Lee SH, Byrne EM, Hultman CM, Kähler A, Vinkhuyzen AA, Ripke S, Andreassen OA, Frisell T, Gusev A, Hu X, Karlsson R, Mantzioris VX, McGrath JJ, Mehta D, Stahl EA, ... ... Linszen DH, et al. New data and an old puzzle: the negative association between schizophrenia and rheumatoid arthritis. International Journal of Epidemiology. PMID 26286434 DOI: 10.1093/Ije/Dyv136 |
0.346 |
|
| 2015 |
Maat A, van Montfort SJ, de Nijs J, Derks EM, Kahn RS, Linszen DH, van Os J, Wiersma D, Bruggeman R, Cahn W, de Haan L, Krabbendam L, Myin-Germeys I. Emotion processing in schizophrenia is state and trait dependent. Schizophrenia Research. 161: 392-8. PMID 25543332 DOI: 10.1016/J.Schres.2014.11.027 |
0.376 |
|
| 2015 |
van Tricht MJ, Bour LJ, Koelman JH, Derks EM, Braff DL, de Wilde OM, Boerée T, Linszen DH, de Haan L, Nieman DH. Qualitative and quantitative aspects of information processing in first psychosis: latent class analyses in patients, at-risk subjects, and controls. Psychophysiology. 52: 585-93. PMID 25376718 DOI: 10.1111/Psyp.12379 |
0.338 |
|
| 2015 |
Ising HK, Smit F, Veling W, Rietdijk J, Dragt S, Klaassen RM, Savelsberg NS, Boonstra N, Nieman DH, Linszen DH, Wunderink L, van der Gaag M. Cost-effectiveness of preventing first-episode psychosis in ultra-high-risk subjects: multi-centre randomized controlled trial. Psychological Medicine. 45: 1435-46. PMID 25330734 DOI: 10.1017/S0033291714002530 |
0.311 |
|
| 2015 |
van Tricht MJ, Nieman DH, Koelman JT, Mensink AJ, Bour LJ, van der Meer JN, van Amelsvoort TA, Linszen DH, de Haan L. Sensory gating in subjects at ultra high risk for developing a psychosis before and after a first psychotic episode. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 16: 12-21. PMID 22730901 DOI: 10.3109/15622975.2012.680911 |
0.366 |
|
| 2015 |
Smeerdijk M, Keet R, Van Raaij B, Koeter M, Linszen D, De Haan L, Schippers G. Motivational interviewing and interaction skills training for parents of young adults with recent-onset schizophrenia and co-occurring cannabis use: 15-month follow-up Psychological Medicine. 45: 2839-2848. DOI: 10.1017/S0033291715000793 |
0.401 |
|
| 2014 |
Gaag Mvd, Ising HK, Savelsberg NSP, Burger NAFM, Willebrands-Mendrik M, Rietdijk J, Klaassen RMC, Boonstra N, Nieman D, Dragt S, Linszen DH, Wunderink L. Four-year outcome of the Dutch EDIE trial: the prevention of transition to psychosis in ultrahigh risk patients Early Intervention in Psychiatry. 8: 16-16. PMID 25387722 DOI: 10.1111/Eip.12185 |
0.317 |
|
| 2014 |
De Koning MB, Bloemen OJ, Van Duin ED, Booij J, Abel KM, De Haan L, Linszen DH, Van Amelsvoort TA. Pre-pulse inhibition and striatal dopamine in subjects at an ultra-high risk for psychosis. Journal of Psychopharmacology (Oxford, England). 28: 553-560. PMID 24526133 DOI: 10.1177/0269881113519507 |
0.386 |
|
| 2014 |
van Tricht MJ, Ruhrmann S, Arns M, Müller R, Bodatsch M, Velthorst E, Koelman JH, Bour LJ, Zurek K, Schultze-Lutter F, Klosterkötter J, Linszen DH, de Haan L, Brockhaus-Dumke A, Nieman DH. Can quantitative EEG measures predict clinical outcome in subjects at Clinical High Risk for psychosis? A prospective multicenter study. Schizophrenia Research. 153: 42-7. PMID 24508483 DOI: 10.1016/J.Schres.2014.01.019 |
0.324 |
|
| 2014 |
von Reventlow HG, Krüger-Özgürdal S, Ruhrmann S, Schultze-Lutter F, Heinz A, Patterson P, Heinimaa M, Dingemans P, French P, Birchwood M, Salokangas RK, Linszen D, Morrison A, Klosterkötter J, Juckel G. Pathways to care in subjects at high risk for psychotic disorders - a European perspective. Schizophrenia Research. 152: 400-7. PMID 24377700 DOI: 10.1016/J.Schres.2013.11.031 |
0.304 |
|
| 2014 |
Rietdijk J, Fokkema M, Stahl D, Valmaggia L, Ising HK, Dragt S, Klaassen RM, Nieman DH, Loewy R, Cuijpers P, Delespaul P, Linszen DH, van der Gaag M. The distribution of self-reported psychotic-like experiences in non-psychotic help-seeking mental health patients in the general population; a factor mixture analysis. Social Psychiatry and Psychiatric Epidemiology. 49: 349-58. PMID 24126556 DOI: 10.1007/S00127-013-0772-1 |
0.332 |
|
| 2014 |
Bramon E, Pirinen M, Strange A, Lin K, Freeman C, Bellenguez C, Su Z, Band G, Pearson R, Vukcevic D, Langford C, Deloukas P, Hunt S, ... ... Linszen DH, et al. A genome-wide association analysis of a broad psychosis phenotype identifies three loci for further investigation. Biological Psychiatry. 75: 386-97. PMID 23871474 DOI: 10.1016/J.Biopsych.2013.03.033 |
0.395 |
|
| 2014 |
Meijer C, Barkhof E, Sonneville Ld, Linszen D, Haan Ld. Poster #M194 THE EFFECT OF MOTIVATIONAL INTERVIEWING ON MEDICATION ADHERENCE AND HOSPITALIZATION RATES IN NONADHERENT PATIENTS WITH MULTI-EPISODE SCHIZOPHRENIA Schizophrenia Research. 153. DOI: 10.1016/S0920-9964(14)70744-3 |
0.367 |
|
| 2014 |
Gaag Mvd, Smit F, Bechdolf A, French P, Linszen DH, Yung A, McGorry P, Cuijpers P. Preventing a first episode of psychosis: a meta-analysis Schizophrenia Research. 153. DOI: 10.1016/S0920-9964(14)70138-0 |
0.326 |
|
| 2013 |
Barkhof E, Meijer CJ, de Sonneville LM, Linszen DH, de Haan L. The effect of motivational interviewing on medication adherence and hospitalization rates in nonadherent patients with multi-episode schizophrenia. Schizophrenia Bulletin. 39: 1242-51. PMID 24072808 DOI: 10.1093/Schbul/Sbt138 |
0.379 |
|
| 2013 |
da Silva Alves F, Bakker G, Schmitz N, Abeling N, Hasler G, van der Meer J, Nederveen A, de Haan L, Linszen D, van Amelsvoort T. Dopaminergic modulation of the reward system in schizophrenia: a placebo-controlled dopamine depletion fMRI study. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 1577-86. PMID 23978392 DOI: 10.1016/J.Euroneuro.2013.06.008 |
0.358 |
|
| 2013 |
van Tricht MJ, Harmsen EC, Koelman JH, Bour LJ, van Amelsvoort TA, Linszen DH, de Haan L, Nieman DH. Effects of cannabis use on event related potentials in subjects at ultra high risk for psychosis and healthy controls. International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology. 88: 149-56. PMID 23541998 DOI: 10.1016/J.Ijpsycho.2013.03.012 |
0.329 |
|
| 2013 |
Nieman DH, Velthorst E, Becker HE, de Haan L, Dingemans PM, Linszen DH, Birchwood M, Patterson P, Salokangas RK, Heinimaa M, Heinz A, Juckel G, von Reventlow HG, Morrison A, Schultze-Lutter F, et al. The Strauss and Carpenter Prognostic Scale in subjects clinically at high risk of psychosis. Acta Psychiatrica Scandinavica. 127: 53-61. PMID 22775300 DOI: 10.1111/J.1600-0447.2012.01899.X |
0.385 |
|
| 2013 |
Bloemen OJ, de Koning MB, Gleich T, Meijer J, de Haan L, Linszen DH, Booij J, van Amelsvoort TA. Striatal dopamine D2/3 receptor binding following dopamine depletion in subjects at Ultra High Risk for psychosis. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 126-32. PMID 22591910 DOI: 10.1016/J.Euroneuro.2012.04.015 |
0.401 |
|
| 2013 |
de Haan L, Sterk B, Wouters L, Linszen DH. The 5-year course of obsessive-compulsive symptoms and obsessive-compulsive disorder in first-episode schizophrenia and related disorders. Schizophrenia Bulletin. 39: 151-60. PMID 21799212 DOI: 10.1093/Schbul/Sbr077 |
0.427 |
|
| 2012 |
Scheltema Beduin AA, Swets M, Machielsen M, Korver N, Kahn RS, Linszen DH, Van Os J, Wiersma D, Bruggeman R, Cahn W, De Haan L, Krabbendam L, Myin-Germeys I. Obsessive-compulsive symptoms in patients with schizophrenia: A naturalistic cross-sectional study comparing treatment with clozapine, olanzapine, risperidone, and no antipsychotics in 543 patients Journal of Clinical Psychiatry. 73: 1395-1402. PMID 23218156 DOI: 10.4088/JCP.11m07164 |
0.342 |
|
| 2012 |
de Koning MB, Boot E, Bloemen OJ, van Duin ED, Abel KM, de Haan L, Linszen DH, van Amelsvoort TA. Startle reactivity and prepulse inhibition of the acoustic startle response are modulated by catechol-O-methyl-transferase Val(158) Met polymorphism in adults with 22q11 deletion syndrome. Journal of Psychopharmacology (Oxford, England). 26: 1548-60. PMID 22952320 DOI: 10.1177/0269881112456610 |
0.343 |
|
| 2012 |
Ising HK, Veling W, Loewy RL, Rietveld MW, Rietdijk J, Dragt S, Klaassen RM, Nieman DH, Wunderink L, Linszen DH, van der Gaag M. The validity of the 16-item version of the Prodromal Questionnaire (PQ-16) to screen for ultra high risk of developing psychosis in the general help-seeking population. Schizophrenia Bulletin. 38: 1288-96. PMID 22516147 DOI: 10.1093/Schbul/Sbs068 |
0.311 |
|
| 2012 |
Velthorst E, Meijer C, Kahn RS, Linszen DH, vanOs J, Wiersm D, Bruggeman R, Cahn W, de Haan L, Krabbendam L, Myin-Germeys I. The association between social anhedonia, withdrawal and psychotic experiences in general and high-risk populations Schizophrenia Research. 138: 290-294. PMID 22484023 DOI: 10.1016/j.schres.2012.03.022 |
0.318 |
|
| 2012 |
Dekker N, Meijer J, Koeter M, van den Brink W, van Beveren N, Kahn RS, Linszen DH, van Os J, Wiersma D, Bruggeman R, Cahn W, de Haan L, Krabbendam L, Myin-Germeys I. Age at onset of non-affective psychosis in relation to cannabis use, other drug use and gender. Psychological Medicine. 42: 1903-11. PMID 22452790 DOI: 10.1017/S0033291712000062 |
0.308 |
|
| 2012 |
Rietdijk J, Klaassen R, Ising H, Dragt S, Nieman DH, van de Kamp J, Cuijpers P, Linszen D, van der Gaag M. Detection of people at risk of developing a first psychosis: comparison of two recruitment strategies. Acta Psychiatrica Scandinavica. 126: 21-30. PMID 22335365 DOI: 10.1111/J.1600-0447.2012.01839.X |
0.31 |
|
| 2012 |
Smeerdijk M, Keet R, Dekker N, Van Raaij B, Krikke M, Koeter M, De Haan L, Barrowclough C, Schippers G, Linszen D. Motivational interviewing and interaction skills training for parents to change cannabis use in young adults with recent-onset schizophrenia: A randomized controlled trial Psychological Medicine. 42: 1627-1636. PMID 22152121 DOI: 10.1017/S0033291711002832 |
0.379 |
|
| 2012 |
Dragt S, Nieman DH, Schultze-Lutter F, van der Meer F, Becker H, de Haan L, Dingemans PM, Birchwood M, Patterson P, Salokangas RK, Heinimaa M, Heinz A, Juckel G, Graf von Reventlow H, French P, ... ... Linszen DH, et al. Cannabis use and age at onset of symptoms in subjects at clinical high risk for psychosis. Acta Psychiatrica Scandinavica. 125: 45-53. PMID 21883099 DOI: 10.1111/J.1600-0447.2011.01763.X |
0.396 |
|
| 2012 |
Velthorst E, Nieman DH, Veling W, Klaassen RM, Dragt S, Rietdijk J, Ising H, Wunderink L, Linszen DH, de Haan L, van der Gaag M. Ethnicity and baseline symptomatology in patients with an At Risk Mental State for psychosis. Psychological Medicine. 42: 247-56. PMID 21835093 DOI: 10.1017/S0033291711001486 |
0.369 |
|
| 2012 |
Machielsen M, Beduin AS, Dekker N, Kahn RS, Linszen DH, van Os J, Wiersma D, Bruggeman R, Cahn W, de Haan L, Krabbendam L, Myin-Germeys I. Differences in craving for cannabis between schizophrenia patients using risperidone, olanzapine or clozapine. Journal of Psychopharmacology (Oxford, England). 26: 189-95. PMID 21768161 DOI: 10.1177/0269881111408957 |
0.365 |
|
| 2012 |
Salokangas R, Ruhrmann S, Graf von Reventlow H, Heinimaa M, Svirskis T, Luutonen S, Juckel G, Linszen D, Dingemans P, Birchwood M, Patterson P, Klosterkötter J. O-51 - Axis I diagnoses and transition to psychosis in clinical high-risk patients European Psychiatry. 27: 1. DOI: 10.1016/S0924-9338(12)74151-2 |
0.316 |
|
| 2012 |
Velthorst E, Nieman DH, Linszen DH, Becker HE, de Haan L, Dingemans PM, Birchwood M, Patterson P, Salokangas RK, Heinimaa M, Heinz A, Juckel G, von Reventlow HG, French P, Stevens H, et al. Poster #71 DISABILITY IN PEOPLE CLINICALLY AT HIGH RISK OF PSYCHOSIS Schizophrenia Research. 136: S306. DOI: 10.1016/S0920-9964(12)70904-0 |
0.311 |
|
| 2012 |
Veithorst E, Nieman DH, Veling W, Klaassen RM, Dragt S, Rietdijk J, Ising H, Wunderink L, Linszen DH, Haan L, Gaag Mvd. Poster #70 ETHNICITY AND BASELINE SYMPTOMATOLOGY IN PATIENTS WITH AN AT RISK MENTAL STATE FOR PSYCHOSIS Schizophrenia Research. 136. DOI: 10.1016/S0920-9964(12)70903-9 |
0.363 |
|
| 2012 |
Ruhrmann S, Schultze-Lutter F, Bodatsch M, Linszen D, Salokangas R, Birchwood M, Juckel G, Morrison A, Heinz A, Lewis S, Reventlow Hv, Klosterkotter J. Poster #65 FUNCTIONAL IMPAIRMENT: SHOULD IT BE AN OBLIGATE PART OF CLINICAL CRITERIA FOR AN INCREASED RISK OF DEVELOPING PSYCHOSIS? Schizophrenia Research. 136. DOI: 10.1016/S0920-9964(12)70898-8 |
0.311 |
|
| 2012 |
Nieman DH, Veithorst E, Becker HE, Haan Ld, Linszen D, Birchwood M, Patterson P, Salokangas RKR, Heinimaa M, Juckel G, Reventlow HG, Morrison A, Schultze-Lutter F, Klosterkötter J, Ruhrmann S. Poster #191 THE STRAUSS AND CARPENTER PROGNOSTIC SCALE IN SUBJECTS CLINICALLY AT HIGH RISK OF PSYCHOSIS Schizophrenia Research. 136. DOI: 10.1016/S0920-9964(12)70762-4 |
0.319 |
|
| 2012 |
Bodatsch M, Schultze-Lutter F, Linszen D, Salokangas R, Birchwood M, Juckel G, Morrison A, Heinz A, Reventlow Hv, Klosterkötter J, Ruhrmann S. Poster #66 PERSISTENT POSITIVE SYMPTOMS IN PERSONS AT HIGH RISK OF PSYCHOSIS Schizophrenia Research. 136. DOI: 10.1016/S0920-9964(12)70638-2 |
0.355 |
|
| 2012 |
Salokangas RKR, Dingemans P, Heinimaa M, Svisrskis T, Luutonen S, Klosterkö J, Ruhrmann S, Juckel G, Reventlow HGv, Linszen D, Birchwood M, Patterson P. Poster #253 PREDICTION OF PSYCHOSIS IN CLINICAL HIGH-RISK PATIENTS BY SCHIZOTYPAL PERSONALITY QUESTIONNAIRE Schizophrenia Research. 136. DOI: 10.1016/S0920-9964(12)70565-0 |
0.351 |
|
| 2012 |
Alves FdS, Schmitz N, Abeling N, van der Meer J, Nederveen A, de Haan L, Linszen D, van Amelsvoort T. Poster #20 DOPAMINERGIC MODULATION OF THE REWARD SYSTEM IN SCHIZOPHRENIA: A PLACEBO-CONTROLLED DOPAMINE DEPLETION FMRI STUDY Schizophrenia Research. 136: S98-S99. DOI: 10.1016/S0920-9964(12)70336-5 |
0.371 |
|
| 2012 |
Koning MBD, Bloemen OJN, Duin EDV, Booij J, Haan LD, Linszen DH, Amelsvoort TAMJV. 15:30 Startle Reactivityand Prepulse Inhibition In Subjects At Ultra High Risk For Psychosis: Correlation With Striatal D2/3 Receptor Binding Following Dopamine Depletion Schizophrenia Research. 136. DOI: 10.1016/S0920-9964(12)70297-9 |
0.324 |
|
| 2011 |
Korver-Nieberg N, Quee PJ, Boos HB, Simons CJ, Kahn RS, Linszen DH, Van Os J, Krabbendam L, Myin-Germeys I, Wiersma D, Bruggeman R. The validity of the DSM-IV diagnostic classification system of non-affective psychoses Australian and New Zealand Journal of Psychiatry. 45: 1061-1068. PMID 22026404 DOI: 10.3109/00048674.2011.620562 |
0.337 |
|
| 2011 |
Rietdijk J, Hogerzeil SJ, van Hemert AM, Cuijpers P, Linszen DH, van der Gaag M. Pathways to psychosis: help-seeking behavior in the prodromal phase. Schizophrenia Research. 132: 213-9. PMID 21907547 DOI: 10.1016/J.Schres.2011.08.009 |
0.309 |
|
| 2011 |
Klaassen RM, Velthorst E, Nieman DH, de Haan L, Becker HE, Dingemans PM, van de Fliert JR, van der Gaag M, Linszen DH. Factor analysis of the scale of prodromal symptoms: differentiating between negative and depression symptoms. Psychopathology. 44: 379-85. PMID 21847005 DOI: 10.1159/000325169 |
0.314 |
|
| 2011 |
Meijer JH, Schmitz N, Nieman DH, Becker HE, van Amelsvoort TA, Dingemans PM, Linszen DH, de Haan L. Semantic fluency deficits and reduced grey matter before transition to psychosis: a voxelwise correlational analysis. Psychiatry Research. 194: 1-6. PMID 21831606 DOI: 10.1016/J.Pscychresns.2011.01.004 |
0.342 |
|
| 2011 |
da Silva Alves F, Schmitz N, Bloemen O, van der Meer J, Meijer J, Boot E, Nederveen A, de Haan L, Linszen D, van Amelsvoort T. White matter abnormalities in adults with 22q11 deletion syndrome with and without schizophrenia. Schizophrenia Research. 132: 75-83. PMID 21831603 DOI: 10.1016/J.Schres.2011.07.017 |
0.415 |
|
| 2011 |
Simon AE, Velthorst E, Nieman DH, Linszen D, Umbricht D, de Haan L. Ultra high-risk state for psychosis and non-transition: a systematic review. Schizophrenia Research. 132: 8-17. PMID 21784618 DOI: 10.1016/J.Schres.2011.07.002 |
0.33 |
|
| 2011 |
da Silva Alves F, Boot E, Schmitz N, Nederveen A, Vorstman J, Lavini C, Pouwels PJ, Pouwels P, de Haan L, Linszen D, van Amelsvoort T. Proton magnetic resonance spectroscopy in 22q11 deletion syndrome. Plos One. 6: e21685. PMID 21738766 DOI: 10.1371/Journal.Pone.0021685 |
0.335 |
|
| 2011 |
Velthorst E, Nieman DH, Meijer C, Linszen D, de Haan L. Social disability at admission for a first psychosis does not predict clinical outcome at 5-year follow-up. The Journal of Nervous and Mental Disease. 199: 510-2. PMID 21716066 DOI: 10.1097/Nmd.0B013E3182214469 |
0.342 |
|
| 2011 |
van Tricht MJ, Nieman DH, Koelman JH, Bour LJ, van der Meer JN, van Amelsvoort TA, Linszen DH, de Haan L. Auditory ERP components before and after transition to a first psychotic episode. Biological Psychology. 87: 350-7. PMID 21536095 DOI: 10.1016/J.Biopsycho.2011.04.005 |
0.331 |
|
| 2011 |
Bloemen OJ, Gleich T, de Koning MB, da Silva Alvis F, de Haan L, Linszen DH, Booij J, van Amelsvoort TA. Hippocampal glutamate levels and striatal dopamine D(2/3) receptor occupancy in subjects at ultra high risk of psychosis. Biological Psychiatry. 70: e1-2; author reply e. PMID 21481842 DOI: 10.1016/J.Biopsych.2010.11.030 |
0.317 |
|
| 2011 |
Boot E, Booij J, Abeling N, Meijer J, da Silva Alves F, Zinkstok J, Baas F, Linszen D, van Amelsvoort T. Dopamine metabolism in adults with 22q11 deletion syndrome, with and without schizophrenia--relationship with COMT Val¹â°â¸/¹âµâ¸Met polymorphism, gender and symptomatology. Journal of Psychopharmacology (Oxford, England). 25: 888-95. PMID 21447540 DOI: 10.1177/0269881111400644 |
0.419 |
|
| 2011 |
Sterk B, Lankreijer K, Linszen DH, de Haan L. Obsessive-compulsive symptoms in first episode psychosis and in subjects at ultra high risk for developing psychosis; onset and relationship to psychotic symptoms. The Australian and New Zealand Journal of Psychiatry. 45: 400-6. PMID 21087087 DOI: 10.3109/00048674.2010.533363 |
0.412 |
|
| 2011 |
Kahn RS, Linszen DH, Van Os J, Wiersma D, Bruggeman R, Cahn W, De Haan L, Krabbendam L, Myin-Germeys I. Evidence that familial liability for psychosis is expressed as differential sensitivity to cannabis: An analysis of patient-sibling and sibling-control pairs Archives of General Psychiatry. 68: 138-147. PMID 20921112 DOI: 10.1001/Archgenpsychiatry.2010.132 |
0.352 |
|
| 2011 |
Dragt S, Nieman DH, Veltman D, Becker HE, van de Fliert R, de Haan L, Linszen DH. Environmental factors and social adjustment as predictors of a first psychosis in subjects at ultra high risk. Schizophrenia Research. 125: 69-76. PMID 20884179 DOI: 10.1016/J.Schres.2010.09.007 |
0.361 |
|
| 2011 |
Velthorst E, Nieman DH, Klaassen RM, Becker HE, Dingemans PM, Linszen DH, De Haan L. Three-year course of clinical symptomatology in young people at ultra high risk for transition to psychosis. Acta Psychiatrica Scandinavica. 123: 36-42. PMID 20712825 DOI: 10.1111/J.1600-0447.2010.01593.X |
0.37 |
|
| 2011 |
Niessen MAJ, Dingemans PMAJ, van de Fliert R, Becker HE, Nieman DH, Linszen D. Diagnostic validity of the Eppendorf Schizophrenia Inventory (ESI): A self-report screen for ultrahigh risk and acute psychosis": Correction to Niessen et al. (2010). Psychological Assessment. 23: 233-233. DOI: 10.1037/A0022823 |
0.344 |
|
| 2011 |
van der Gaag M, Rietdijk J, Ising H, Dragt S, Klaassen R, Nieman D, Wunderink L, Linszen D. Predictors of persistence of ultrahigh risk symptoms and predictors of transition into psychosis European Psychiatry. 26: 2086-2086. DOI: 10.1016/S0924-9338(11)73789-0 |
0.383 |
|
| 2011 |
Salokangas R, Svirskis T, Heinimaa M, Klosterkötter J, Ruhrmann S, Graf von Reventlow H, Linszen D, Dingemans P, Birchwood M, Patterson P. Subjective quality of life and its changes in patients at-risk for psychosis results of the EPOS study European Psychiatry. 26: 2039-2039. DOI: 10.1016/S0924-9338(11)73742-7 |
0.386 |
|
| 2011 |
Ruhrmann S, Schultze-Lutter F, Salokangas RKR, Linszen D, Birchwood M, Juckel G, Heinz A, Lewis S, Klosterkötter J. S08-01 - Course of psychopathology in the at-risk mental state - outcomes beyond transition to psychosis European Psychiatry. 26: 2037-2037. DOI: 10.1016/S0924-9338(11)73740-3 |
0.426 |
|
| 2010 |
Niessen MA, Dingemans PM, van de Fliert R, Becker HE, Nieman DH, Linszen D. Diagnostic validity of the Eppendorf Schizophrenia Inventory (ESI): a self-report screen for ultrahigh risk and acute psychosis. Psychological Assessment. 22: 935-44. PMID 21133552 DOI: 10.1037/A0020974 |
0.386 |
|
| 2010 |
Velthorst E, Nieman DH, Linszen D, Becker H, de Haan L, Dingemans PM, Birchwood M, Patterson P, Salokangas RK, Heinimaa M, Heinz A, Juckel G, von Reventlow HG, French P, Stevens H, et al. Disability in people clinically at high risk of psychosis. The British Journal of Psychiatry : the Journal of Mental Science. 197: 278-84. PMID 20884950 DOI: 10.1192/Bjp.Bp.109.075036 |
0.327 |
|
| 2010 |
van Nimwegen-Campailla L, van Beveren N, Laan W, van den Brink W, Linszen D, de Haan L. Effect of early dysphoric response and cannabis use on discontinuation of olanzapine or risperidone in patients with early psychosis. Pharmacopsychiatry. 43: 281. PMID 20839158 DOI: 10.1055/S-0030-1263172 |
0.326 |
|
| 2010 |
Sterk B, Slief EM, Blankers M, Linszen DH, de Haan L. Duration of untreated psychosis and ethnicity. Schizophrenia Research. 124: 238-9. PMID 20724112 DOI: 10.1016/J.Schres.2010.07.024 |
0.32 |
|
| 2010 |
van Tricht MJ, Nieman DH, Koelman JH, van der Meer JN, Bour LJ, de Haan L, Linszen DH. Reduced parietal P300 amplitude is associated with an increased risk for a first psychotic episode. Biological Psychiatry. 68: 642-8. PMID 20627236 DOI: 10.1016/J.Biopsych.2010.04.022 |
0.346 |
|
| 2010 |
van Tricht MJ, Nieman DH, Bour LJ, Boerée T, Koelman JH, de Haan L, Linszen DH. Increased saccadic rate during smooth pursuit eye movements in patients at Ultra High Risk for developing a psychosis. Brain and Cognition. 73: 215-21. PMID 20538400 DOI: 10.1016/J.Bandc.2010.05.005 |
0.346 |
|
| 2010 |
Talamini LM, de Haan L, Nieman DH, Linszen DH, Meeter M. Reduced context effects on retrieval in first-episode schizophrenia. Plos One. 5: e10356. PMID 20436915 DOI: 10.1371/Journal.Pone.0010356 |
0.417 |
|
| 2010 |
Dragt S, Nieman DH, Becker HE, van de Fliert R, Dingemans PM, de Haan L, van Amelsvoort TA, Linszen DH. Age of onset of cannabis use is associated with age of onset of high-risk symptoms for psychosis. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 55: 165-71. PMID 20370967 DOI: 10.1177/070674371005500308 |
0.378 |
|
| 2010 |
Rietdijk J, Dragt S, Klaassen R, Ising H, Nieman D, Wunderink L, Delespaul P, Cuijpers P, Linszen D, van der Gaag M. A single blind randomized controlled trial of cognitive behavioural therapy in a help-seeking population with an At Risk Mental State for psychosis: The Dutch Early Detection and Intervention Evaluation (EDIE-NL) trial Trials. 11. PMID 20307268 DOI: 10.1186/1745-6215-11-30 |
0.328 |
|
| 2010 |
Korver N, Nieman DH, Becker HE, van de Fliert JR, Dingemans PH, de Haan L, Spiering M, Schmitz N, Linszen DH. Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls. The Australian and New Zealand Journal of Psychiatry. 44: 230-6. PMID 20180725 DOI: 10.1016/J.Schres.2010.02.182 |
0.377 |
|
| 2010 |
Becker HE, Nieman DH, Wiltink S, Dingemans PM, van de Fliert JR, Velthorst E, de Haan L, van Amelsvoort TA, Linszen DH. Neurocognitive functioning before and after the first psychotic episode: does psychosis result in cognitive deterioration? Psychological Medicine. 40: 1599-606. PMID 20132582 DOI: 10.1017/S0033291710000048 |
0.313 |
|
| 2010 |
Becker HE, Nieman DH, Dingemans PM, van de Fliert JR, De Haan L, Linszen DH. Verbal fluency as a possible predictor for psychosis. European Psychiatry : the Journal of the Association of European Psychiatrists. 25: 105-10. PMID 20005685 DOI: 10.1016/J.Eurpsy.2009.08.003 |
0.402 |
|
| 2010 |
Dekker N, Schmitz N, Peters BD, van Amelsvoort TA, Linszen DH, de Haan L. Cannabis use and callosal white matter structure and integrity in recent-onset schizophrenia. Psychiatry Research. 181: 51-6. PMID 19962862 DOI: 10.1016/J.Pscychresns.2009.06.003 |
0.419 |
|
| 2010 |
Peters BD, Dingemans PM, Dekker N, Blaas J, Akkerman E, van Amelsvoort TA, Majoie CB, den Heeten GJ, Linszen DH, de Haan L. White matter connectivity and psychosis in ultra-high-risk subjects: a diffusion tensor fiber tracking study. Psychiatry Research. 181: 44-50. PMID 19954931 DOI: 10.1016/J.Pscychresns.2009.10.008 |
0.331 |
|
| 2010 |
Dekker N, Smeerdijk AM, Wiers RW, Duits JH, van Gelder G, Houben K, Schippers G, Linszen DH, de Haan L. Implicit and explicit affective associations towards cannabis use in patients with recent-onset schizophrenia and healthy controls. Psychological Medicine. 40: 1325-36. PMID 19917142 DOI: 10.1017/S0033291709991814 |
0.411 |
|
| 2010 |
Bloemen OJ, de Koning MB, Schmitz N, Nieman DH, Becker HE, de Haan L, Dingemans P, Linszen DH, van Amelsvoort TA. White-matter markers for psychosis in a prospective ultra-high-risk cohort. Psychological Medicine. 40: 1297-304. PMID 19895720 DOI: 10.1017/S0033291709991711 |
0.355 |
|
| 2010 |
Salokangas RKR, Ruhrmann S, Heinimaa M, Svirskis T, Laine T, Reventlow HGv, Juckel G, Linszen D, Dingemans P, Birchwood M, Patterson P, Klosterkötter J. Axis I Diagnoses And Transition To Psychosis In High Risk Patients. Results Of The Epos Project Schizophrenia Research. 117: 515-516. DOI: 10.1016/J.Schres.2010.02.988 |
0.322 |
|
| 2010 |
Sterk B, Landreijer K, Linszen D, Haan Ld. Obsessive Compulsive Symptoms In First Episode Psychosis And In Subjects At Ultra High Risk To Develop Psychosis; Onset And Relationship To Psychotic Symptoms Schizophrenia Research. 117: 457-457. DOI: 10.1016/J.Schres.2010.02.852 |
0.384 |
|
| 2010 |
Sterk B, Slief E, Landreijer K, Linszen D, Haan Ld. Poster 159DURATION OF UNTREATED PSYCHOSIS AND ETHNICITY Schizophrenia Research. 117. DOI: 10.1016/J.Schres.2010.02.654 |
0.322 |
|
| 2010 |
Nieman D, Becker H, Haan L, Gaag Mvd, Denys D, Linszen D. Prescription of antipsychotic medication to patients at ultra high risk for developing psychosis in a naturalistic setting Schizophrenia Research. 117: 301-301. DOI: 10.1016/J.Schres.2010.02.500 |
0.347 |
|
| 2010 |
Dragt S, Nieman DH, Becker HE, de Fliert JRv, de Haan L, Linszen DH. SOCIO-DEMOGRAPHIC CHARACTERISTICS AND SOCIAL ADJUSTMENT AS PREDICTORS OF A FIRST PSYCHOSIS IN SUBJECTS AT ULTRA HIGH RISK Schizophrenia Research. 117: 287. DOI: 10.1016/J.Schres.2010.02.473 |
0.312 |
|
| 2010 |
Haan LD, Sterk B, Wouters L, Linszen D. The Five Year Course Of Obsessive-Compulsive Symptoms In First Episode Schizophrenia Schizophrenia Research. 117: 178-179. DOI: 10.1016/J.Schres.2010.02.216 |
0.419 |
|
| 2009 |
Peters BD, de Koning P, Dingemans P, Becker H, Linszen DH, de Haan L. Subjective effects of cannabis before the first psychotic episode. The Australian and New Zealand Journal of Psychiatry. 43: 1155-62. PMID 20001415 DOI: 10.3109/00048670903179095 |
0.439 |
|
| 2009 |
Dekker N, Linszen DH, De Haan L. Reasons for cannabis use and effects of cannabis use as reported by patients with psychotic disorders. Psychopathology. 42: 350-60. PMID 19752588 DOI: 10.1159/000236906 |
0.365 |
|
| 2009 |
Nieman DH, Rike WH, Becker HE, Dingemans PM, van Amelsvoort TA, de Haan L, van der Gaag M, Denys DA, Linszen DH. Prescription of antipsychotic medication to patients at ultra high risk of developing psychosis. International Clinical Psychopharmacology. 24: 223-8. PMID 19521246 DOI: 10.1097/Yic.0B013E32832E0A76 |
0.34 |
|
| 2009 |
de Koning MB, Bloemen OJ, van Amelsvoort TA, Becker HE, Nieman DH, van der Gaag M, Linszen DH. Early intervention in patients at ultra high risk of psychosis: benefits and risks. Acta Psychiatrica Scandinavica. 119: 426-42. PMID 19392813 DOI: 10.1111/J.1600-0447.2009.01372.X |
0.362 |
|
| 2009 |
Peters BD, Schmitz N, Dingemans PM, van Amelsvoort TA, Linszen DH, de Haan L, Majoie CB, den Heeten GJ. Preliminary evidence for reduced frontal white matter integrity in subjects at ultra-high-risk for psychosis. Schizophrenia Research. 111: 192-3. PMID 19372031 DOI: 10.1016/J.Schres.2009.03.018 |
0.339 |
|
| 2009 |
Salokangas RKR, Heinimaa M, Svirskis T, Laine T, Huttunen J, Ristkari T, Ilonen T, Korkeila J, Vaskelainen L, Rekola J, Hietala J, Klosterkötter J, Ruhrmann S, Reventlow HGv, Linszen D, et al. Perceived negative attitude of others as an early sign of psychosis. European Psychiatry. 24: 233-238. PMID 19201166 DOI: 10.1016/J.Eurpsy.2008.12.011 |
0.423 |
|
| 2008 |
de Wilde OM, Bour LJ, Dingemans PM, Koelman JH, Boerée T, Linszen DH. P300 deficits are present in young first-episode patients with schizophrenia and not in their healthy young siblings. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 119: 2721-6. PMID 18986832 DOI: 10.1016/J.Clinph.2008.08.024 |
0.429 |
|
| 2008 |
Peters BD, de Haan L, Dekker N, Blaas J, Becker HE, Dingemans PM, Akkerman EM, Majoie CB, van Amelsvoort T, den Heeten GJ, Linszen DH. White matter fibertracking in first-episode schizophrenia, schizoaffective patients and subjects at ultra-high risk of psychosis. Neuropsychobiology. 58: 19-28. PMID 18781087 DOI: 10.1159/000154476 |
0.454 |
|
| 2008 |
de Haan L, Nimwegen Lv, Amelsvoort Tv, Dingemans P, Linszen D. Improvement of subjective well-being and enduring symptomatic remission, a 5-year follow-up of first episode schizophrenia. Pharmacopsychiatry. 41: 125-8. PMID 18651339 DOI: 10.1055/S-2008-1076729 |
0.394 |
|
| 2008 |
van Nimwegen LJ, de Haan L, van Beveren NJ, van der Helm M, van den Brink W, Linszen D. Effect of olanzapine and risperidone on subjective well-being and craving for cannabis in patients with schizophrenia or related disorders: a double-blind randomized controlled trial. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 53: 400-5. PMID 18616861 DOI: 10.1177/070674370805300610 |
0.426 |
|
| 2008 |
van Nimwegen L, de Haan L, van Beveren N, Laan W, van den Brink W, Linszen D. Obsessive-compulsive symptoms in a randomized, double-blind study with olanzapine or risperidone in young patients with early psychosis. Journal of Clinical Psychopharmacology. 28: 214-8. PMID 18344733 DOI: 10.1097/Jcp.0B013E318166F520 |
0.406 |
|
| 2008 |
van der Feltz-Cornelis CM, Aldenkamp AP, Adèr HJ, Boenink A, Linszen D, Van Dyck R. Psychosis in epilepsy patients and other chronic medically ill patients and the role of cerebral pathology in the onset of psychosis: a clinical epidemiological study. Seizure. 17: 446-56. PMID 18262441 DOI: 10.1016/J.Seizure.2007.12.004 |
0.329 |
|
| 2008 |
Sprong M, Becker HE, Schothorst PF, Swaab H, Ziermans TB, Dingemans PM, Linszen D, van Engeland H. Pathways to psychosis: a comparison of the pervasive developmental disorder subtype Multiple Complex Developmental Disorder and the "At Risk Mental State". Schizophrenia Research. 99: 38-47. PMID 18055179 DOI: 10.1016/J.Schres.2007.10.031 |
0.31 |
|
| 2008 |
de Haan L, van Amelsvoort T, Dingemans P, Linszen D. Risk factors for medication non-adherence in patients with first episode schizophrenia and related disorders; a prospective five year follow-up. Pharmacopsychiatry. 40: 264-8. PMID 18030650 DOI: 10.1055/S-2007-992141 |
0.432 |
|
| 2008 |
Zinkstok J, Nimwegen Lv, Amelsvoort Tv, Haan Ld, Yusuf MA, Baas F, Linszen D. Catechol-O-methyltransferase gene and obsessive-compulsive symptoms in patients with recent-onset schizophrenia: preliminary results. Psychiatry Research-Neuroimaging. 157: 1-8. PMID 17850881 DOI: 10.1016/J.Psychres.2007.02.001 |
0.423 |
|
| 2008 |
Boot E, Booij J, Zinkstok J, Abeling N, de Haan L, Baas F, Linszen D, van Amelsvoort T. Disrupted dopaminergic neurotransmission in 22q11 deletion syndrome. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 33: 1252-8. PMID 17653112 DOI: 10.1038/Sj.Npp.1301508 |
0.308 |
|
| 2008 |
Zinkstok J, Schmitz N, van Amelsvoort T, Moeton M, Baas F, Linszen D. Genetic variation in COMT and PRODH is associated with brain anatomy in patients with schizophrenia. Genes, Brain, and Behavior. 7: 61-9. PMID 17504246 DOI: 10.1111/J.1601-183X.2007.00326.X |
0.37 |
|
| 2008 |
Linszen D. Continuity Of Care And Parent Groups In Early Schizophrenia: A 5 Year Randomized Controlled Trial Schizophrenia Research. 102: 258. DOI: 10.1016/S0920-9964(08)70776-X |
0.354 |
|
| 2008 |
van Amelsvoort T, Schmitz N, Zinkstok J, de Haan L, Baas F, Linszen D. EFFECT OF BDNF VAL66MET POLYMORPHISM ON BRAIN ANATOMY IN FIRST EPISODE SCHIZOPHRENIA Schizophrenia Research. 102: 83. DOI: 10.1016/S0920-9964(08)70254-8 |
0.354 |
|
| 2008 |
Schmitz N, van Amelsvoort T, Denys D, Linszen D, de Haan L. WHITE MATTER ABNORMALITIES IN PATIENTS WITH SCHIZOPHRENIA AND OBSESSIVE-COMPULSIVE DISORDER Schizophrenia Research. 102: 81. DOI: 10.1016/S0920-9964(08)70247-0 |
0.435 |
|
| 2008 |
Dekker N, Schmitz N, Peters BD, van Amelsvoort TA, Linszen DH, de Haan L. WHITE MATER INTEGRITY IN SCHIZOPHRENIA AND ADOLESCENT-ONSET CANNABIS USE Schizophrenia Research. 102: 80-81. DOI: 10.1016/S0920-9964(08)70246-9 |
0.363 |
|
| 2008 |
Salokangas RK, Heinimaa M, Svirskis T, Klosterkoetter J, Ruhrmann S, Reventlow HGv, Linszen DH, Dingemans PM, Birchwood M, Patterson P, Juckel G, Morrison A. Subjective quality of life and its changes in patients at risk of psychosis European Psychiatry. 23. DOI: 10.1016/J.Eurpsy.2008.01.247 |
0.313 |
|
| 2007 |
de Wilde OM, Bour L, Dingemans P, Boerée T, Linszen D. Antisaccade deficit is present in young first-episode patients with schizophrenia but not in their healthy young siblings. Psychological Medicine. 38: 871-5. PMID 17949519 DOI: 10.1017/S0033291707001894 |
0.447 |
|
| 2007 |
Nieman D, Becker H, van de Fliert R, Plat N, Bour L, Koelman H, Klaassen M, Dingemans P, Niessen M, Linszen D. Antisaccade task performance in patients at ultra high risk for developing psychosis Schizophrenia Research. 95: 54-60. PMID 17656071 DOI: 10.1016/J.Schres.2007.06.022 |
0.416 |
|
| 2007 |
Zinkstok JR, de Wilde O, van Amelsvoort TA, Tanck MW, Baas F, Linszen DH. Association between the DTNBP1 gene and intelligence: a case-control study in young patients with schizophrenia and related disorders and unaffected siblings. Behavioral and Brain Functions : Bbf. 3: 19. PMID 17445278 DOI: 10.1186/1744-9081-3-19 |
0.395 |
|
| 2007 |
de Wilde OM, Bour LJ, Dingemans PM, Koelman JH, Linszen DH. Failure to find P50 suppression deficits in young first-episode patients with schizophrenia and clinically unaffected siblings. Schizophrenia Bulletin. 33: 1319-23. PMID 17289652 DOI: 10.1093/Schbul/Sbm001 |
0.421 |
|
| 2007 |
Linszen D, Amelsvoort Tv. Cannabis and psychosis: an update on course and biological plausible mechanisms. Current Opinion in Psychiatry. 20: 116-120. PMID 17278907 DOI: 10.1097/Yco.0B013E32803577Fb |
0.311 |
|
| 2007 |
Wilde Od, Bour L, Dingemans P, Boerée T, Linszen D. Visual scan paths in young patients with schizophrenia, healthy siblings and controls Schizophrenia Research. 89: 362-363. PMID 17010575 DOI: 10.1016/J.Schres.2006.08.027 |
0.397 |
|
| 2007 |
Salokangas R, Heinimaa M, Klosterkoetter J, Ruhrman S, Graf von Reventlow H, Linszen D, Dingemans P, Birchwood M, Patterson P. Premorbid adjustment in persons at high risk for psychosis European Psychiatry. 22: S64. DOI: 10.1016/J.Eurpsy.2007.01.248 |
0.32 |
|
| 2006 |
de Haan L, Hoogeboom B, Beuk N, Wouters L, Dingemans PM, Linszen DH. Reliability and validity of the Yale-Brown Obsessive-Compulsive Scale in schizophrenia patients. Psychopharmacology Bulletin. 39: 25-30. PMID 17065972 |
0.345 |
|
| 2006 |
Klaassen MC, Nieman DH, Becker HE, Linszen DH. [Is there any point in detecting high risk factors prior to a first psychosis?]. Tijdschrift Voor Psychiatrie. 48: 467-76. PMID 16956006 |
0.326 |
|
| 2006 |
de Haan L, Booij J, Lavalaye J, van Amelsvoort T, Linszen D. Occupancy of dopamine D2 receptors by antipsychotic drugs is related to nicotine addiction in young patients with schizophrenia. Psychopharmacology. 183: 500-5. PMID 16292589 DOI: 10.1007/S00213-005-0218-X |
0.333 |
|
| 2006 |
Barkhof E, de Haan L, Meijer CJ, Fouwels AJ, Keet IPM, Hulstijn KP, Schippers GM, Linszen DH. Motivational interviewing in psychotic disorders Current Psychiatry Reviews. 2: 207-213. DOI: 10.2174/157340006776875932 |
0.418 |
|
| 2006 |
Keet IPM, Hulstijn KP, Haan Ld, Schippers G, Linszen D. 0251 Family Motivational Intervention: Training Motivational Interviewing for Family Members of Patients With Schizophrenia, Cannabis Use and Poor Compliance Schizophrenia Research. 86. DOI: 10.1016/S0920-9964(06)70445-5 |
0.344 |
|
| 2006 |
Dingemans PMAJ, Becker HE, Fliert JRvd, Niessen MAJ, Nieman DH, Linszen DH. 0481 Personality Pathology Traits And High Risk For Psychosis Schizophrenia Research. 86. DOI: 10.1016/S0920-9964(06)70282-1 |
0.303 |
|
| 2006 |
Heinimaa M, Salokangas RKR, Klosterkötter J, Linszen D, Birchwood M. 0447 Axis-I Diagnoses In Patients At Risk Of Psychotic Conversion Schizophrenia Research. 86. DOI: 10.1016/S0920-9964(06)70278-X |
0.343 |
|
| 2006 |
Heinimaa MLA, Huttunen J, Svirskis T, Korkeila J, Salokangas RKR, Linszen D, Birchwood M, Klosterkötter J. 0350 Axis-I Diagnoses In Patients At Risk Of Psychotic Conversion Schizophrenia Research. 86. DOI: 10.1016/S0920-9964(06)70272-9 |
0.343 |
|
| 2006 |
Becker HE, Nieman DH, Fliert JRvd, Dingemans PM, Linszen DH. 0320 Cognitive Functioning In Patients At Ultra High Risk For Psychosis: Relation With Daily Life Functioning Schizophrenia Research. 86. DOI: 10.1016/S0920-9964(06)70268-7 |
0.304 |
|
| 2006 |
Becker HE, Nieman DH, Dingemans PM, Fliert JRvd, Linszen DH. 0080 Verbal Fluency In Patients At Ultra High Risk For Psychosis Schizophrenia Research. 86. DOI: 10.1016/S0920-9964(06)70251-1 |
0.36 |
|
| 2006 |
Fliert JRvd, Becker HE, Dingemans PMAJ, Nieman DH, Niessen MAJ, Linszen DH. 0071 Patients At High Risk For Psychosis: Level Of Functioning And Handicaps Of The Transition And Non-Transition Group Schizophrenia Research. 86. DOI: 10.1016/S0920-9964(06)70250-X |
0.302 |
|
| 2006 |
Klaassen MC, Nieman DH, Haan Ld, Becker HE, Dingemans PM, Linszen DH, Fliert Rvd. 0539 Differentiation Between Depressive And Negative Symptoms In Patients At Ultra High Risk For Psychosis Schizophrenia Research. 86. DOI: 10.1016/S0920-9964(06)70243-2 |
0.353 |
|
| 2006 |
Niessen MA, Dingemans PMAJ, Becker HE, Fliert JRvd, Nieman DH, Linszen DH. 0357 Validity Of The Eppendorf Schizophrenia Inventory (Esi)As A Screening Device In High Risk Assessment Schizophrenia Research. 86. DOI: 10.1016/S0920-9964(06)70237-7 |
0.373 |
|
| 2006 |
Linszen D, Haan LD, Dingemans P, Lenior R, Amelsvoort TV, Wouters L. Fc10D The Amsterdam Critical Period Intervention In The Early Phase Of Schizophrenia-Like Psychoses Schizophrenia Research. 86. DOI: 10.1016/S0920-9964(06)70184-0 |
0.371 |
|
| 2006 |
Wilde OMd, Dingemans PM, Bour LJ, Boeree T, Linszen DH. Fc10C Misperception In First-Episode Patients With Schizophrenia And Their Healthy Young Siblings Schizophrenia Research. 86. DOI: 10.1016/S0920-9964(06)70183-9 |
0.444 |
|
| 2006 |
Salokangas RKR, Heinimaa M, Svirskis T, Klosterkötter J, Ruhrmann S, Reventlow HGv, Linszen D, Dingemans P, Birchwood M, Patterson P. Fc2F Premorbid Adjustment And Severity Of Psychopathology And Functioning In Patients At Risk Of Psychosis Schizophrenia Research. 86. DOI: 10.1016/S0920-9964(06)70108-6 |
0.361 |
|
| 2006 |
Salokangas RKR, Heinimaa M, Klosterkötter J, Ruhrmann S, Reventlow HGv, Linszen D, Dingemans P, Birchwood M, Patterson P. Wc3C Probably Prodromal, But Certainly Ill: Quality Of Life And Social Adjustment In Patients At Risk Of Psychosis. Results Of The Epos Study Schizophrenia Research. 86. DOI: 10.1016/S0920-9964(06)70027-5 |
0.307 |
|
| 2005 |
Haan Ld, Hoogenboom B, Beuk N, Amelsvoort Tv, Linszen D. Obsessive-Compulsive Symptoms and Positive, Negative, and Depressive Symptoms in Patients with Recent-Onset Schizophrenic Disorders The Canadian Journal of Psychiatry. 50: 519-524. PMID 16262106 DOI: 10.1177/070674370505000904 |
0.401 |
|
| 2005 |
Lenior ME, Dingemans PM, Schene AH, Linszen DH. Predictors of the early 5-year course of schizophrenia: a path analysis. Schizophrenia Bulletin. 31: 781-91. PMID 16123531 DOI: 10.1093/Schbul/Sbi010 |
0.421 |
|
| 2005 |
Nimwegen Lv, Haan Ld, Beveren Nv, Brink Wvd, Linszen D. Adolescence, schizophrenia and drug abuse: a window of vulnerability. Acta Psychiatrica Scandinavica. 111: 35-42. PMID 15877720 DOI: 10.1111/J.1600-0447.2005.00543.X |
0.368 |
|
| 2005 |
Storosum JG, Wohlfarth T, Gispen-de Wied CC, Linszen DH, Gersons BP, van Zwieten BJ, van den Brink W. Suicide risk in placebo-controlled trials of treatment for acute manic episode and prevention of manic-depressive episode. The American Journal of Psychiatry. 162: 799-802. PMID 15800158 DOI: 10.1176/Appi.Ajp.162.4.799 |
0.617 |
|
| 2004 |
Haan LD, Oekeneva A, Amelsvoort TV, Linszen D. Obsessive-compulsive disorder and treatment with clozapine in 200 patients with recent-onset schizophrenia or related disorders. European Psychiatry. 19: 524-524. PMID 15589719 DOI: 10.1016/J.Eurpsy.2004.09.022 |
0.395 |
|
| 2004 |
Kho KH, Blansjaar BA, de Vries S, Babuskova D, Zwinderman AH, Linszen DH. Electroconvulsive therapy for the treatment of clozapine nonresponders suffering from schizophrenia--an open label study. European Archives of Psychiatry and Clinical Neuroscience. 254: 372-9. PMID 15538604 DOI: 10.1007/s00406-004-0517-y |
0.317 |
|
| 2004 |
Amelsvoort Tv, Henry J, Morris R, Owen M, Linszen D, Murphy K, Murphy D. Cognitive deficits associated with schizophrenia in velo-cardio-facial syndrome Schizophrenia Research. 70: 223-232. PMID 15329299 DOI: 10.1016/J.Schres.2003.10.004 |
0.422 |
|
| 2004 |
de Haan L, Lavalaye J, van Bruggen M, van Nimwegen L, Booij J, van Amelsvoort T, Linszen D. Subjective experience and dopamine D2 receptor occupancy in patients treated with antipsychotics: clinical implications. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 49: 290-6. PMID 15198464 DOI: 10.1177/070674370404900503 |
0.386 |
|
| 2004 |
de Haan L, Welborn K, Krikke M, Linszen DH. Opinions of mothers on the first psychotic episode and the start of treatment of their child. European Psychiatry : the Journal of the Association of European Psychiatrists. 19: 226-9. PMID 15196605 DOI: 10.1016/J.Eurpsy.2003.09.010 |
0.345 |
|
| 2004 |
de Haan L, van Amelsvoort T, Linszen DH. Elevated homocysteine levels in schizophrenia. The American Journal of Psychiatry. 161: 1131-2; author reply. PMID 15169714 DOI: 10.1176/Appi.Ajp.161.6.1131-A |
0.396 |
|
| 2003 |
Van Bruggen J, Tijssen J, Dingemans P, Gersons B, Linszen D. Symptom response and side-effects of olanzapine and risperidone in young adults with recent onset schizophrenia International Clinical Psychopharmacology. 18: 341-346. PMID 14571154 DOI: 10.1097/00004850-200311000-00005 |
0.647 |
|
| 2003 |
de Haan L, van Bruggen M, Lavalaye J, Booij J, Dingemans PM, Linszen D. Subjective experience and D2 receptor occupancy in patients with recent-onset schizophrenia treated with low-dose olanzapine or haloperidol: a randomized, double-blind study. The American Journal of Psychiatry. 160: 303-9. PMID 12562577 DOI: 10.1176/Appi.Ajp.160.2.303 |
0.393 |
|
| 2003 |
Wilde OMd, Linszen DH. Meta-analysis of P50 research in schizophrenia Schizophrenia Research. 60: 249. DOI: 10.1016/S0920-9964(03)81268-9 |
0.376 |
|
| 2003 |
Peters BD, Vlieger E, Haan Ld, Majoie CB, Heeten GJd, Linszen DH. Reduced white matter integrity in recent-onset schizophrenia as assessed with diffusion tensor imaging Schizophrenia Research. 60: 204-205. DOI: 10.1016/S0920-9964(03)81141-6 |
0.342 |
|
| 2003 |
van Amelsvoort T, Henry J, Morris R, Owen M, Linszen D, Murphy K, Murphy D. Cognitive deficits associated with schizophrenia in adults with velocardio-facial syndrome Schizophrenia Research. 60: 91. DOI: 10.1016/S0920-9964(03)80658-8 |
0.357 |
|
| 2003 |
Lenior ME, Dingemans PM, Schene AH, Linszen DH. Predictors and five-year outcome in early-onset schizophrenia. A path analysis Schizophrenia Research. 60: 292. DOI: 10.1016/S0920-9964(03)80488-7 |
0.382 |
|
| 2003 |
Linszen DH, Haan Ld, Dingemans P, Bruggen Mv, Hofstra N, Engelsdorp Hv, Smitten Mt. Treatment reluctance in first episode schizophrenia: Lack of insight, non-compliance and cannabis abuse predict bad outcome after eighteen months intervention Schizophrenia Research. 60: 325. DOI: 10.1016/S0920-9964(03)80290-6 |
0.377 |
|
| 2002 |
Haan Ld, Peters B, Dingemans P, Wouters L, Linszen D. Attitudes of Patients Toward the First Psychotic Episode and the Start of Treatment Schizophrenia Bulletin. 28: 431-442. PMID 12645675 DOI: 10.1093/Oxfordjournals.Schbul.A006951 |
0.377 |
|
| 2002 |
Lenior ME, Dingemans PM, Schene AH, Hart AA, Linszen DH. The course of parental expressed emotion and psychotic episodes after family intervention in recent-onset schizophrenia. A longitudinal study. Schizophrenia Research. 57: 183-90. PMID 12223249 DOI: 10.1016/S0920-9964(01)00305-X |
0.348 |
|
| 2002 |
de Haan L, Weisfelt M, Dingemans PM, Linszen DH, Wouters L. Psychometric properties of the Subjective Well-Being Under Neuroleptics scale and the Subjective Deficit Syndrome Scale. Psychopharmacology. 162: 24-8. PMID 12107613 DOI: 10.1007/S00213-002-1054-X |
0.335 |
|
| 2002 |
Wolthaus JE, Dingemans PM, Schene AH, Linszen DH, Wiersma D, Van Den Bosch RJ, Cahn W, Hijman R. Caregiver burden in recent-onset schizophrenia and spectrum disorders: the influence of symptoms and personality traits. The Journal of Nervous and Mental Disease. 190: 241-7. PMID 11960085 DOI: 10.1097/00005053-200204000-00005 |
0.419 |
|
| 2002 |
Nieman DH, Koelman JH, Linszen DH, Bour LJ, Dingemans PM, Ongerboer de Visser BW. Clinical and neuropsychological correlates of the P300 in schizophrenia. Schizophrenia Research. 55: 105-13. PMID 11955970 DOI: 10.1016/S0920-9964(01)00184-0 |
0.341 |
|
| 2002 |
Wolthaus J, Dingemans P, Schene A, Linszen D, Wiersma D, Bosch vdR, Cahn W, Hijman R. Caregiver burden in recent-onset schizophrenia and spectrum disorders Journal of Nervous and Mental Disease. 190: 241-247. DOI: 10.1097/01.Nmd.0000012872.08131.50 |
0.4 |
|
| 2001 |
Lavalaye J, Booij J, Linszen DH, Reneman L, van Royen EA. Higher occupancy of muscarinic receptors by olanzapine than risperidone in patients with schizophrenia. A[123I]-IDEX SPECT study. Psychopharmacology. 156: 53-7. PMID 11465633 DOI: 10.1007/S002130000679 |
0.393 |
|
| 2001 |
Lenior ME, Dingemans PM, Linszen DH, de Haan L, Schene AH. Social functioning and the course of early-onset schizophrenia: five-year follow-up of a psychosocial intervention. The British Journal of Psychiatry : the Journal of Mental Science. 179: 53-8. PMID 11435269 DOI: 10.1192/Bjp.179.1.53 |
0.376 |
|
| 2001 |
Lavalaye J, Sarlet A, Booij J, Linszen DH, Reneman L, Gersons BP, van Royen EA. Dopamine transporter density in patients with tardive dyskinesia: a single photon emission computed tomography study. Psychopharmacology. 155: 107-9. PMID 11374328 DOI: 10.1007/S002130000670 |
0.617 |
|
| 2001 |
Lavalaye J, Linszen DH, Booij J, Dingemans PM, Reneman L, Habraken JB, Gersons BP, van Royen EA. Dopamine transporter density in young patients with schizophrenia assessed with [123]FP-CIT SPECT. Schizophrenia Research. 47: 59-67. PMID 11163545 DOI: 10.1016/S0920-9964(00)00023-2 |
0.661 |
|
| 2000 |
Wolthaus JE, Dingemans PM, Schene AH, Linszen DH, Knegtering H, Holthausen EA, Cahn W, Hijman R. Component structure of the positive and negative syndrome scale (PANSS) in patients with recent-onset schizophrenia and spectrum disorders. Psychopharmacology. 150: 399-403. PMID 10958081 DOI: 10.1007/S002130000459 |
0.402 |
|
| 2000 |
de Haan L, Lavalaye J, Linszen D, Dingemans PM, Booij J. Subjective experience and striatal dopamine D(2) receptor occupancy in patients with schizophrenia stabilized by olanzapine or risperidone. The American Journal of Psychiatry. 157: 1019-20. PMID 10831489 DOI: 10.1176/Appi.Ajp.157.6.1019 |
0.408 |
|
| 2000 |
Nieman DH, Bour LJ, Linszen DH, Goede J, Koelman JH, Gersons BP, Ongerboer de Visser BW. Neuropsychological and clinical correlates of antisaccade task performance in schizophrenia. Neurology. 54: 866-71. PMID 10690978 DOI: 10.1212/Wnl.54.4.866 |
0.669 |
|
| 2000 |
Lavalaye J, Linszen DH, Booij J. No change in striatal dopamine transporter density in antipsychotic-naive patients with schizophrenia assessed with 123I-FP-CIT SPECT Schizophrenia Research. 41: 252. DOI: 10.1016/S0920-9964(00)90935-6 |
0.397 |
|
| 2000 |
Haan Ld, Peters B, Dingemans P, Wouters L, Linszen D. Attitudes of patients concerning the first psychotic episode and the start of treatment Schizophrenia Research. 41: 227. DOI: 10.1016/S0920-9964(00)90870-3 |
0.318 |
|
| 2000 |
Bruggen JMv, Linszen DH, Dingemans PMAJ. Weight gain as side-effect of olanzapine and risperidone in adolescent patients with schizophrenia Schizophrenia Research. 41: 196. DOI: 10.1016/S0920-9964(00)90781-3 |
0.382 |
|
| 2000 |
Haan Ld, Beuk N, Linszen DH, Dingemans P. Obsessive-compulsive symptoms during treatment with olanzapine or risperidone. Preliminary results from a prospective study Schizophrenia Research. 41: 191. DOI: 10.1016/S0920-9964(00)90766-7 |
0.314 |
|
| 2000 |
Haan Ld, Lavalaye J, Linszen D, Dingemans P, Booij J. Subjective experience and striatal dopamine D2 receptor occupancy in patients with recent-onset schizophrenia treated with olanzapine or risperidone Schizophrenia Research. 41: 26. DOI: 10.1016/S0920-9964(00)90358-X |
0.413 |
|
| 2000 |
Linszen DH, Lenior MA, Dingemans PM. The duration of intervention in early recognized schizophrenia and other psychoses Schizophrenia Research. 41: 9. DOI: 10.1016/S0920-9964(00)90326-8 |
0.391 |
|
| 1999 |
Lavalaye J, Linszen DH, Booij J, Reneman L, Gersons BP, van Royen EA. Dopamine D2 receptor occupancy by olanzapine or risperidone in young patients with schizophrenia. Psychiatry Research. 92: 33-44. PMID 10688158 DOI: 10.1016/S0925-4927(99)00032-3 |
0.623 |
|
| 1999 |
de Haan L, Linszen DH, Gorsira R. Clozapine and obsessions in patients with recent-onset schizophrenia and other psychotic disorders. The Journal of Clinical Psychiatry. 60: 364-5. PMID 10401913 |
0.332 |
|
| 1998 |
Linszen DH, Dingemans PM, Lenior ME, Scholte WF, de Haan L, Goldstein MJ. Early detection and intervention in schizophrenia. International Clinical Psychopharmacology. 13: S31-4. PMID 9690968 DOI: 10.1097/00004850-199803003-00006 |
0.394 |
|
| 1998 |
Linszen D, Lenior M, de Haan L, Dingemans P, Gersons B. Early intervention, untreated psychosis and the course of early schizophrenia British Journal of Psychiatry. 172: 84-89. DOI: 10.1192/S0007125000297717 |
0.362 |
|
| 1998 |
Dingemans PMAJ, Lenior ME, Linszen DH. Personality and schizophrenic relapse International Clinical Psychopharmacology. 13: S89-S95. DOI: 10.1097/00004850-199801001-00015 |
0.417 |
|
| 1998 |
Nieman DH, Ongerboer De Visser BW, Koelman JHTM, Hofman WF, Linszen DH. The P3 event-related potential in young recent-onset schizophrenic patients International Clinical Psychopharmacology. 13: S67-S73. DOI: 10.1097/00004850-199801001-00012 |
0.38 |
|
| 1998 |
Linszen DH, Dingemans PMAJ, Scholte WF, Lenior ME, Goldstein M. Early recognition, intensive intervention and other protective and risk factors for psychotic relapse in patients with first psychotic episodes in schizophrenia International Clinical Psychopharmacology. 13: S7-S12. DOI: 10.1097/00004850-199801001-00003 |
0.351 |
|
| 1998 |
Linszen D, Dingemans P, Lenior M, de Haan L, Scholte P. Early intervention and the course of recent onset schizophrenia European Psychiatry. 13: 144s-144s. DOI: 10.1016/S0924-9338(99)80047-9 |
0.393 |
|
| 1998 |
Linszen DH, Dingemans PMAJ, Lenior MA. Early intervention and the course of schizophrenia Schizophrenia Research. 29: 159. DOI: 10.1016/S0920-9964(97)88708-7 |
0.387 |
|
| 1997 |
Nugter MA, Dingemans PM, Linszen DH, Van der Does AJ, Gersons BP. The relationships between expressed emotion, affective style and communication deviance in recent-onset schizophrenia. Acta Psychiatrica Scandinavica. 96: 445-51. PMID 9421341 DOI: 10.1111/J.1600-0447.1997.Tb09946.X |
0.639 |
|
| 1997 |
Nugter A, Dingemans P, Van Does JWD, Linszen D, Gersons B. Family treatment, expressed emotion and relapse in recent onset schizophrenia Psychiatry Research. 72: 23-31. PMID 9355816 DOI: 10.1016/S0165-1781(97)00086-3 |
0.626 |
|
| 1997 |
Nugter MA, Dingemans PM, Linszen DH, Van der Does AJ, Gersons BP. Parental communication deviance: its stability and the effect of family treatment in recent-onset schizophrenia. Acta Psychiatrica Scandinavica. 95: 199-204. PMID 9111852 DOI: 10.1111/J.1600-0447.1997.Tb09620.X |
0.618 |
|
| 1997 |
Linszen DH, Dingemans PM, Nugter MA, Van der Does AJ, Scholte WF, Lenior MA. Patient attributes and expressed emotion as risk factors for psychotic relapse. Schizophrenia Bulletin. 23: 119-30. PMID 9050118 DOI: 10.1093/Schbul/23.1.119 |
0.373 |
|
| 1997 |
Linszen DH, Lenior ME, Dingemans PM. Untreated psychosis and early intervention in recent onset schizophrenia Schizophrenia Research. 24: 225. DOI: 10.1016/S0920-9964(97)82649-7 |
0.402 |
|
| 1996 |
Van der Does AJ, Dingemans PM, Linszen DH, Nugter MA, Scholte WF. Symptoms, cognitive and social functioning in recent-onset schizophrenia: a longitudinal study. Schizophrenia Research. 19: 61-71. PMID 9147497 DOI: 10.1016/0920-9964(95)00046-1 |
0.417 |
|
| 1995 |
Dingemans PM, Linszen DH, Lenior ME, Smeets RM. Component structure of the expanded Brief Psychiatric Rating Scale (BPRS-E). Psychopharmacology. 122: 263-7. PMID 8748395 DOI: 10.1007/Bf02246547 |
0.392 |
|
| 1995 |
Willem Van der Does AJ, Dingemans PM, Linszen DH, Nugter MA, Scholte WF. Dimensions and subtypes of recent-onset schizophrenia. A longitudinal analysis. The Journal of Nervous and Mental Disease. 183: 681-7. PMID 7595429 DOI: 10.1097/00005053-199511000-00002 |
0.393 |
|
| 1995 |
Linszen DH, Dingemans PM, Lenior ME. Symptom dimensions of schizophrenia and cannabis abuse: A longitudinal study Schizophrenia Research. 15: 16. DOI: 10.1016/0920-9964(95)95061-D |
0.418 |
|
| 1994 |
Linszen DH, Dingemans PM, Lenior ME, Nugter MA, Scholte WF, Van der Does AJ. Relapse criteria in schizophrenic disorders: different perspectives. Psychiatry Research. 54: 273-81. PMID 7792331 DOI: 10.1016/0165-1781(94)90021-3 |
0.402 |
|
| 1993 |
Van der Does AJ, Linszen DH, Dingemans PM, Nugter MA, Scholte WF. A dimensional and categorical approach to the symptomatology of recent-onset schizophrenia. The Journal of Nervous and Mental Disease. 181: 744-9. PMID 8254326 DOI: 10.1097/00005053-199312000-00006 |
0.381 |
|
| Show low-probability matches. |
